Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Simple blood tests which could predict the severity of osteoarthritis

Bristol researchers are hoping to develop simple blood tests which could predict the severity of osteoarthritis, a common, disabling joint condition which affects more than two million people in the UK.

29 Mar 2004

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

26 Mar 2004

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.

26 Mar 2004

Thyroid disorders are often misdiagnosed

Thyroid disorders are among the most common medical conditions. However, because their symptoms often appear gradually, the condition is often misdiagnosed, according to Dr. Nila Vora, a board-certified endocrinologist at the Loyola Primary Care Center in Darien.

25 Mar 2004

Raptiva, 20 percent improvement in an individual's signs and symptoms of arthritis.

Genentech, Inc. and XOMA Ltd. today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVA™ (efalizumab) in 107 patients with psoriatic arthritis. The study did not reach statistical significance at 12 weeks (84 days) for the primary endpoint, ACR 20 response. An ACR 20 response indicates at least a 20 percent improvement in an individual's signs and symptoms of arthritis.

22 Mar 2004

Lupus Discovery May Lead To Improved Drugs

In an important development in the treatment of lupus as well as certain cancers, scientists at the Feinberg School of Medicine at Northwestern University have discovered how autoimmune lupus T cells stave off programmed cell death and drive production of autoantibodies directed against the body’s own DNA.

22 Mar 2004

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Simple blood tests which could predict the severity of osteoarthritis

New patent to develop antibody therapies for cancer and other diseases

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

Thyroid disorders are often misdiagnosed

Raptiva, 20 percent improvement in an individual's signs and symptoms of arthritis.

Lupus Discovery May Lead To Improved Drugs

How do mass spectrometry and omics impact neurosciences?

Meet Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Simple blood tests which could predict the severity of osteoarthritis

New patent to develop antibody therapies for cancer and other diseases

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

Thyroid disorders are often misdiagnosed

Raptiva, 20 percent improvement in an individual's signs and symptoms of arthritis.

Lupus Discovery May Lead To Improved Drugs

How do mass spectrometry and omics impact neurosciences?

Meet Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

Newsletters you may be interested in